BG Medicine, Inc. (BGMD)

BG Medicine Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Feb 17, 2026	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Market Capitalization	0	4	16	29	47	92
Market Cap Growth	-100.00%	-74.40%	-45.36%	-38.69%	-48.48%	-
Enterprise Value	-	4	14	26	40	65
Last Close Price	0.00	0.36	1.84	4.16	9.24	18.88
PS Ratio	0.00	2.59	5.69	7.13	16.82	56.25
PB Ratio	0.00	6.57	28.49	-27.16	153.27	4.40
P/TBV Ratio	-	-	37.60	-	-	4.50
EV/Sales Ratio	-	2.56	4.88	6.40	14.08	39.52
Debt / Equity Ratio	-	-	5.31	-6.84	31.90	-
Net Debt / Equity Ratio	-2.47	-2.47	-2.09	0.41	-9.48	-1.14
Net Debt / EBITDA Ratio	0.35	0.35	0.17	0.03	0.13	1.40
Net Debt / FCF Ratio	0.42	0.42	0.14	0.03	0.14	1.59
Asset Turnover	0.43	0.43	0.38	0.33	0.14	0.10
Inventory Turnover	1.85	1.85	2.23	3.07	2.90	-
Quick Ratio	1.45	1.45	0.94	1.10	1.59	4.61
Current Ratio	1.65	1.65	1.06	1.20	1.75	4.87
Return on Equity (ROE)	-902.64%	-902.64%	-	-	-224.22%	-222.22%
Return on Assets (ROA)	-75.95%	-75.95%	-59.65%	-73.06%	-68.70%	-65.96%
Return on Capital Employed (ROCE)	-469.40%	-469.40%	-1070.50%	-717.60%	-328.20%	-83.60%
Earnings Yield	-63254545.45%	-130.57%	-50.82%	-54.58%	-50.19%	-19.13%
FCF Yield	-	-90.29%	-51.47%	-53.11%	-45.22%	-16.38%
Buyback Yield / Dilution	-17.54%	-17.54%	-20.18%	-34.61%	-14.62%	-493.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.